Sign in

You're signed outSign in or to get full access.

Scott Wagner

Director at DoubleVerify Holdings
Board

About Scott Wagner

Scott Wagner, age 54, has served as an independent director of DoubleVerify since October 2021 (Class III; term expiring 2027). He is the former CEO of GoDaddy (2017–2019), previously President/COO/CFO at GoDaddy (2012–2017), and most recently served as Interim CEO of GoodRx; earlier he was a Member (Partner) at KKR (elected 2010; at KKR 2000–2012) and began his career at Boston Consulting Group. He holds an MBA from Harvard Business School and a BA in Economics from Yale University .

Past Roles

OrganizationRoleTenureCommittees/Impact
GoDaddy Inc.Chief Executive Officer2017–2019Oversaw IPO and operational transformation to global SaaS platform
GoDaddy Inc.President, COO & CFO2012–2017Scaled platform serving SMBs; finance and operations leadership
GoodRxInterim Chief Executive OfficerMost recent prior to DV bio dateInterim leadership at public healthcare technology company
KKR & Co. Inc.Member (Partner); investment professionalPartner elected 2010; worked 2000–2012Growth investing experience; portfolio oversight
Boston Consulting GroupConsultantEarly careerStrategy experience

External Roles

OrganizationTypeRoleNotes
GoodRxPublic companyDirectorCurrent public board service
GoFundMe, Inc.Private companyDirectorPrivate growth company board
Kajabi, LLCPrivate companyDirectorPrivate growth company board

Board Governance

  • Committee assignments: Chair, Compensation Committee; Member, Nominating & Governance Committee; not on Audit Committee .
  • Independence: Board determined Wagner is independent under NYSE rules .
  • Attendance: Board held 4 meetings in 2024; each director attended at least 75% of Board and committee meetings (Wagner met attendance standard) .
  • Executive sessions: Non-management and independent director sessions held regularly; independent-only session at least annually .
  • Board leadership/structure: Non-executive Chair (R. Davis Noell); classified board (classes I–III); Board pledged to sunset classified structure and certain supermajority features within 3 years .

Fixed Compensation

Compensation Item2024 Amount ($)Notes
Annual cash retainer40,000Standard director cash retainer
Compensation Committee Chair retainer15,000Chair premium for Compensation Committee
Nominating & Governance Committee member retainer5,000Member fee
Total fees earned in cash60,000Sum of cash retainers
Annual equity grant (RSUs; grant-date fair value)200,003RSUs vest on earlier of May 23, 2025 or 2025 Annual Meeting date
Total director compensation (2024)260,003Cash + equity

Performance Compensation

ElementDesignPerformance Metric(s)Vesting
Annual equityRSUs (time-based)None (no performance-linked director pay)One-year vest; earlier of May 23, 2025 or 2025 Annual Meeting

DV’s non-employee director program consists of cash retainers and time-based RSUs; there are no director options or PSUs, and no performance metrics tied to director compensation .

Other Directorships & Interlocks

CompanyRoleCommittee Roles (DV)Interlock/Conflict Notes
GoodRxDirectorDV Compensation Chair; DV Nominating memberDV discloses no compensation committee interlocks in 2024
GoFundMe, Inc.DirectorPrivate company; no DV interlock disclosed
Kajabi, LLCDirectorPrivate company; no DV interlock disclosed
  • Compensation Committee interlocks: None in 2024 (no DV executive served on another company’s compensation committee with reciprocal overlap) .
  • Related person transaction policy: Audit Committee must review/approve transactions >$120,000 involving Related Persons; no specific related person transactions involving Wagner are identified in the proxy .

Expertise & Qualifications

  • Technology/software, operations and strategic planning expertise; senior management track record as public company CEO (GoDaddy) .
  • Corporate finance experience from KKR; public company board service (GoodRx) .
  • Education: MBA (Harvard), BA Economics (Yale) .

Equity Ownership

CategoryAmountNotes
Beneficial ownership (shares)31,917Held via Hilltopper LLC; <1% of outstanding
RSUs outstanding at 12/31/202410,724Aggregate director RSUs outstanding; no options
Right to acquire within 60 days10,724Right to acquire shares via RSU vesting (standard director grants)
Pledging/HedgingPolicy restrictsDV prohibits short sales/derivatives and requires pre-clearance for any hedging/pledging; no pledging disclosed for Wagner in proxy
Ownership guidelinesIn placeStock ownership guidelines apply to directors (multiple of annual cash retainer; specific multiple not disclosed)

Governance Assessment

  • Strengths: Independent director; chairs Compensation Committee composed entirely of independent directors ; met attendance standards ; DV maintains robust governance (clawback policy for executives, no option repricing, stock ownership guidelines, hedging/pledging controls) supporting investor alignment .

  • Compensation oversight quality: Committee uses an independent consultant (Compensia) with no conflicts; engages in annual reviews of pay structures and risks; no interlocks identified—supports objectivity .

  • Shareholder signals: 2024 Say-on-Pay approval was ~93.5%, indicating strong support of DV’s compensation program (reflects credibility of Compensation Committee chaired by Wagner) .

  • Watch items: Classified board (commitment to sunset within 3 years mitigates concern) ; Providence retains nomination rights via Stockholder’s Agreement, necessitating continued vigilance to ensure independence in committee processes . Wagner’s external public directorship (GoodRx) presents typical outside commitments; no related party transactions with DV are disclosed .

  • RED FLAGS: None identified related to conflicts, related-party transactions, hedging/pledging, or low attendance in the proxy for Wagner; director pay structure is standard (cash + time-based RSUs) without unusual guarantees or modifications .